The Longevity Genes in Founder Populations Project

December 13, 2023 updated by: Albert Einstein College of Medicine

Searching for Longevity Genes in the Historically Unique Ashkenazi Jewish Population

We believe extreme longevity is due to specific genes which function to delay aging and prevent disease. The purpose of our research is to identify the genes/mutations associated with healthier aging; to understand the biological functions of these genes/mutations; and to develop therapies to replicate these preservative genetic activities in individuals who do not have the genetic profile for longevity.

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

1500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02118-2526
        • Recruiting
        • Boston University Medical Center
        • Contact:
          • Thomas Perls, MD, MPH
          • Phone Number: 617-638-7207
    • New York
      • New York, New York, United States, 10065
        • Recruiting
        • Weill Cornell Medical College
        • Contact:
          • Todd Evans, MD
          • Phone Number: 646-962-8200
      • New York, New York, United States
      • Riverdale, New York, United States, 10471
        • Recruiting
        • Hebrew Home Riverdale
        • Contact:
          • Charlotte Dell, LMSW
          • Phone Number: 718-581-1139

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

63 years and older (Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Ashkenazi Jews:

Ages 95 and older, their offspring and control group with no family history of longevity.

Description

Inclusion Criteria:

  • Ashkenazi Jewish, age 95+,
  • Offspring of person age 95+,
  • Offspring of parents who died age 70 or younger.

Exclusion Criteria:

  • Non-Ashkenazis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Probands
Ashkenazi Jews ages 95 and older
Offspring
Ashkenazi Jewish offspring of Ashkenazi Jewish parent(s) who lived to at least the age of 95
Controls
Ashkenazi Jewish people with no family history of longevity

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Nir Barzilai, MD, Albert Einstein College of Medicine

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 1998

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

December 1, 2027

Study Registration Dates

First Submitted

June 27, 2008

First Submitted That Met QC Criteria

June 30, 2008

First Posted (Estimated)

July 1, 2008

Study Record Updates

Last Update Posted (Estimated)

December 19, 2023

Last Update Submitted That Met QC Criteria

December 13, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 1998-125
  • 2U19AG056278-07A1 (U.S. NIH Grant/Contract)
  • 3U19AG056278-06S1 (U.S. NIH Grant/Contract)
  • P01AG021654 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Extreme Longevity

3
Subscribe